Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.22 million shares were traded. PMVP stock price reached its highest trading level at $1.3564 during the session, while it also had its lowest trading level at $1.3.
Ratios:
We take a closer look at PMVP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.76 and its Current Ratio is at 10.76. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 13, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $6.
On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.Jefferies initiated its Buy rating on April 12, 2024, with a $5 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 23 ’25 when ORBIMED ADVISORS LLC sold 1,000,000 shares for $1.52 per share. The transaction valued at 1,520,000 led to the insider holds 4,975,291 shares of the business.
OrbiMed Private Investments V, bought 1,000,000 shares of PMVP for $1,520,000 on Oct 23 ’25. On Sep 10 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the 10% Owner of the company, sold 500,000 shares for $1.80 each. As a result, the insider received 900,000 and left with 5,975,291 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 71303424 and an Enterprise Value of -57015580.
Stock Price History:
The Beta on a monthly basis for PMVP is 1.63, which has changed by -0.17283952 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, PMVP has reached a high of $1.84, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -4.07%, while the 200-Day Moving Average is calculated to be 7.38%.
Shares Statistics:
According to the various share statistics, PMVP traded on average about 1.22M shares per day over the past 3-months and 227210 shares per day over the past 10 days. A total of 52.99M shares are outstanding, with a floating share count of 43.76M. Insiders hold about 17.75% of the company’s shares, while institutions hold 57.52% stake in the company. Shares short for PMVP as of 1763078400 were 1534893 with a Short Ratio of 1.26, compared to 1760486400 on 1526449. Therefore, it implies a Short% of Shares Outstanding of 1534893 and a Short% of Float of 3.4000000000000004.
Earnings Estimates
PMV Pharmaceuticals Inc (PMVP) is presently subject to a detailed evaluation by 4.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.21 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.51 and -$1.58 for the fiscal current year, implying an average EPS of -$1.54. EPS for the following year is -$1.43, with 4.0 analysts recommending between -$0.91 and -$1.65.
